Bay Street News, May 21st, 2020

BOSTON, May 21, 2020 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing […]

IRVINE, Calif., May 21, 2020 (GLOBE NEWSWIRE) — Today’s Work-From-Home environment is now easier and more secure due to video […]

NEW YORK, May 21, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage […]

TOKYO and SAN FRANCISCO, May 21, 2020 (GLOBE NEWSWIRE) — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, […]

Submission of New Drug ApplicationBay Street News

TULSA, Okla., May 21, 2020 (GLOBE NEWSWIRE) — Educational Development Corporation (“EDC”, or the “Company”) (NASDAQ: EDUC) (http://www.edcpub.com) today reports […]

Fiscal Fourth Quarter and Other Recent Highlights:Net investment income per share for the quarter was $0.59 compared to $0.54 for […]

NEW YORK, May 21, 2020 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]

CAMBRIDGE, Mass., May 21, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives […]

TORONTO, May 21, 2020 (GLOBE NEWSWIRE) — Caldas Gold Corp. (the “Company” or “Caldas Gold”) (TSX-V: CGC) is pleased to […]